Ironwood Pharmaceuticals Provides First Quarter 2014 Investor Update

Published: Apr 29, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today provided an update on its first quarter 2014 and recent business activities.

“During the first fifteen months of the LINZESS launch, we have established a strong foundation of physician experience and payer coverage for LINZESS. Now, while we continue advancing with prescribers and payers, we are intensifying our efforts to educate appropriate patients about LINZESS through a multi-channel, direct-to-consumer patient awareness campaign,” said Peter Hecht, chief executive officer of Ironwood.

Help employers find you! Check out all the jobs and post your resume.

Back to news